Literature DB >> 4683231

Coxsackievirus myocarditis: prophylaxis and therapy with an interferon stimulator.

D Norris, P C Loh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4683231     DOI： 10.3181/00379727-142-36975

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  4 in total

Review 1.  Coxsackievirus infection as a trigger of cardiac autoimmunity.

Authors:  L J Wolfgram; N R Rose
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

3.  Role of antiviral antibodies in resistance against coxsackievirus B3 infection: interaction between preexisting antibodies and an interferon inducer.

Authors:  C T Cho; K K Feng; V P McCarthy; M F Lenahan
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

4.  Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production.

Authors:  Qing-Meng Zhang; Wu-Qi Song; Yu-Jun Li; Jun Qian; Ai-Xia Zhai; Jing Wu; Ai-Mei Li; Jun-Ming He; Jin-Yun Zhao; Xin Yu; Lan-Lan Wei; Feng-Min Zhang
Journal:  Virol J       Date:  2012-12-19       Impact factor: 4.099
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.